Blockade Of Focal Adhesion Kinase (FAK) Has Potent Anti-Tumor Activities In Human Renal Cell Carcinoma ORLANDO, FL (UroToday.com) - A group from Strasbourg reported on focal adhesion kinase (FAK), a non-receptor tyrosine kinase in renal clear cell cancer (CRCC). FAK plays critical roles in signal transduction pathways initiated at sites of cell adhesion and at growth factor receptors that are involved in cell adhesion, proliferation, survival and migration.
Source: www.medicalnewstoday.comAmerican Health Lawyers Announces Release Of Fundamentals Of Health Law, Fourth Edition With CD-ROM American
Health Lawyers Association is pleased to announce the release of Fundamentals of
Health Law, Fourth Edition with CD-ROM.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 6:00 PM
